DICOM Networking in Python
Sixth post in a series of posts written by members of the Qurit Team. Written by Adam Watkins.
Part 1: The Handshake
TEAM MEMBERS
Identification of Parkinson’s Disease Subtypes using Radiomics and Machine Learning
Fourth post in a series of posts written by members of the Qurit Team. Written by Mohammad Salmanpour.
Pros of a Multidisciplinary Team
Third post in a series of posts written by members of the Qurit Team. Written by Cassandra Miller.
State-of-the-Art in PET/CT Image Segmentation
Second post in a series of posts written by members of the Qurit Team. Written by Fereshteh Yousefi Rizi, PhD.
Starting a new job with Qurit during COVID-19: What I’m learning
First post in a series of posts written by members of the Qurit Team. Written by Cariad Knight.
Using radioactive epoxy lesions in phantoms
Presentation by our fantastic co-op student, Roberto Fedrigo, to the UBC Multidisciplinary Undergraduate Research Conference (MURC), with title, “Phantom-guided optimization of prostate cancer PET imaging using radioactive epoxy lesions”:
New opening for post-doc fellow in PET/CT imaging
Roberto Fedrigo awarded the 2020 Summer Undergraduate Fellowship by AAPM
Congratulations to Roberto Fedrigo who has been awarded the 2020 Summer Undergraduate Fellowship by the American Association of Physicists in Medicine (AAPM).
New visiting PhD student
We welcome Mohammad Salmanpour, who has been working with us closely since 2017 (from Tehran Polytechnic), now staying with us as exchange PhD student. Mohammad focuses on improved prediction of outcome in Parkinson’s disease (PD) using machine learning algorithms.
Prospective Students
Graduate Students
We actively recruit talented MSc and PhD students from the University of British Columbia Physics, Interdisciplinary Oncology Program, Biomedical Engineering, and Electrical & Computer Engineering.
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.